Dilantin 100mg Extended-Release Capsules

Viatris Dilantin Phenytoin Sodium 100mg Extended Release Capsules

Product Description:
Viatris Dilantin Phenytoin Sodium 100mg Extended Release Capsules are a meticulously formulated anticonvulsant medication designed to manage and control seizures. By stabilizing neuronal membranes and modulating sodium channels in the brain, these capsules help in the reduction of excessive electrical brain activity, which is a common cause of seizures. The extended-release formulation ensures a steady release of phenytoin into the bloodstream, providing consistent therapeutic levels and minimizing the risk of breakthrough seizures.

Technical Specifications:
- Active Ingredient: Phenytoin Sodium
- Strength: 100mg per capsule
- Formulation: Extended-release for prolonged effect
- Administration: Oral
- Packaging: Secure bottles containing various quantities of capsules
- Storage: Store at controlled room temperature, away from moisture and light

Common Applications:
- Management of tonic-clonic (grand mal) seizures
- Prevention and control of seizures occurring during or after neurosurgery
- Treatment of status epilepticus, a severe form of epilepsy marked by continuous seizures

User Groups:
- Individuals diagnosed with epilepsy
- Patients undergoing neurosurgery
- Individuals requiring a stable, extended-release anticonvulsant therapy

Supplier Overview:
Viatris is a global healthcare company that specializes in producing essential medications across a broad range of therapeutic areas. With a commitment to quality, safety, and efficacy, Viatris has established itself as an authority in the pharmaceutical space, particularly in the production of neurological medications like Dilantin. Their extensive experience in drug development and manufacturing, combined with rigorous testing and compliance with international standards, makes Viatris a trusted name for healthcare providers and patients seeking reliable anticonvulsant treatments.